Skip to main content
Robbert  Hoogeboom

Dr Robbert Hoogeboom

Lecturer in Lymphoma

Research interests

  • Cancer

Biography

Dr Robbert Hoogeboom is a Lecturer in Lymphoma within the Comprehensive Cancer Centre. He obtained a PhD at the Academic Medical Centre in Amsterdam, The Netherlands and subsequently became a postdoc at the National Institute for Medical Research/The Francis Crick Institute. In 2018, he joined King's College London as a lecturer. He leads a research group that focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma. His team uses high content imaging of primary patient cells and novel in vivo mouse models to study the context in which malignant B cells see antigen and how antigen stimulation and BCR signalling influence the behaviour of the tumour cells and disease progression.

    Research

    Lymphoma Signalling 780x450
    Lymphoma Signalling

    Our work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma.

      Research

      Lymphoma Signalling 780x450
      Lymphoma Signalling

      Our work focuses on the role of antigen exposure and B cell receptor signalling in the pathogenesis and treatment of B cell leukaemia and lymphoma.